Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-45,786
Closed -$5.38M 1049
2019
Q4
$5.38M Buy
+45,786
New +$4.53M 0.27% 72
2019
Q1
Sell
-54,786
Closed -$2.13M 1676
2018
Q4
$2.13M Buy
54,786
+32,500
+146% +$1.44M 0.14% 220
2018
Q3
$1.27M Buy
+22,286
New +$1.39M 0.06% 477
2018
Q1
Sell
-47,586
Closed -$3.29M 1802
2017
Q4
$3.29M Buy
47,586
+42,611
+857% +$3.41M 0.15% 199
2017
Q3
$452K Buy
+4,975
New +$426K 0.02% 857
2015
Q3
Sell
-21,585
Closed -$1.16M 1642
2015
Q2
$1.16M Buy
21,585
+10,122
+88% +$516K 0.04% 680
2015
Q1
$548K Buy
+11,463
New +$497K 0.02% 882

Other funds holding NVRO

A.R.T. Advisors's NVRO Position: Q1 2020 in Review

A.R.T. Advisors sold out of NEVRO CORP. (NVRO) in Q1 2020, closing a stake of 45,786 shares — an estimated $5.38M sold.

A.R.T. Advisors first reported a position in NVRO in Q1 2015 and held it in 7 quarters. The position peaked at $5.38M in Q4 2019. 182 funds tracked by Wall St. Rank hold NVRO as of Q1 2020.

  • A.R.T. Advisors reported no remaining NEVRO CORP. position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 45,786 NEVRO CORP. shares in Q1 2020, an estimated $5.38M.
  • A.R.T. Advisors first reported a position in NEVRO CORP. in Q1 2015 and held it in 7 quarters.
  • A.R.T. Advisors's NEVRO CORP. position peaked at $5.38M in Q4 2019.
  • 182 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.